T. Baccega

Most-cited papers

1. In vivo CRISPR editing with no detectable genome-wide off-target mutations

   P. Akçakaya, Maggie L. Bobbin, Jimmy A. Guo, José Malagón-López +18 more

   2018Nature284 citations Open access

   Semantic Scholar

   Save

2. Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and Fibrosis

   Bastian Höchst, Julita Mikulec, T. Baccega, C. Metzger +7 more

   2015PLoS ONE51 citations Open access

   Semantic Scholar

   Save

3. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement

   Raniero Chimienti, T. Baccega, S. Torchio, Fabio Manenti +9 more

   2022Cell Reports32 citations Open access

   Semantic Scholar

   Save

4. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis

   Sara Caputo, Matteo Grioni, Chiara S. Brambillasca, A. Monno +12 more

   2020Frontiers in Immunology32 citations Open access

   Semantic Scholar

   Save

5. Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]

   Tobias Kroon, T. Baccega, A. Olsén, J. Gabrielsson +1 more

   2016Journal of Lipid Research18 citations Open access

   Semantic Scholar

   Save

6. In vivo CRISPR-Cas gene editing with no detectable genome-wide off-target mutations

   P. Akçakaya, Maggie L. Bobbin, Jimmy A. Guo, J. M. López +18 more

   2018bioRxiv9 citations Open access

   Semantic Scholar

   Save

7. Dendritic cells steering antigen and leukocyte traffic in lymph nodes

   Enrico Dotta, A. Macioła, T. Baccega, G. Pasqual

   2024FEBS Letters7 citations Open access

   Semantic Scholar

   Save

8. Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editor

   Deborah Cipria, T. Baccega, M. Rizzo, Piergiuseppe Quarato +12 more

   2026Nature Communications2 citations Open access

   Semantic Scholar

   Save

9. Chemical and synthetic biology tools to interrogate and control cell-cell interactions in vivo.

   T. Baccega, Enrico Dotta, G. Pasqual

   2026Current Opinion in Chemical Biology1 citations Open access

   Semantic Scholar

   Save

10. Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I−/− iPSC-derived β cells for cell therapy of type 1 diabetes

    Raniero Chimienti, T. Baccega, Fabio Manenti, S. Torchio +7 more

    20201 citations

    Semantic Scholar

    Save

11. 6TH International Conference on Lymphocyte Engineering 15–17 July 2026 Milan, Italy

    T. Dao, Guang-Yan Xiong, Jeremy Meyerberg, Zita E H Aretz +363 more

    2026Human Gene Therapy0 citations

    Semantic Scholar

    Save

12. Antigen recognition licenses therapeutic CD8+ T cells to organize a multicellular myeloid interaction network in the tumor microenvironment

    Alfredo Pherez-Farah, W. de Koning, Wei-Sha Qi, Gioia Boncompagni +10 more

    2026bioRxiv0 citations Open access

    Semantic Scholar

    Save

13. Ruolo e funzione delle cellule soppressorie di origine mieloide nell'infiammazione renale /Role and functions of myeloid - derived suppressors cells in kidney inflammation

    T. Baccega

    20140 citations

    Semantic Scholar

    Save